Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium

Neonatal Abstinence Syndrome

(2014) P. Kocherlakota   PEDIATRICS

Developmental Changes in Morphine Clearance Across the Entire Paediatric Age Range are Best Described by a Bodyweight-Dependent Exponent Model

(2013) Chenguang Wang et al.   CLINICAL DRUG INVESTIGATION

OCT1 genetic variants influence the pharmacokinetics of morphine in children

(2013) Tsuyoshi Fukuda et al.   PHARMACOGENOMICS

Prediction of Morphine Clearance in the Paediatric Population

(2012) Elke H. J. Krekels et al.   CLINICAL PHARMACOKINETICS

Prediction of morphine dose in humans

(2011) Nick H. G. Holford et al.   PEDIATRIC ANESTHESIA

Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years

(2009) Catherijne A.J. Knibbe et al.   CLINICAL PHARMACOKINETICS

Evaluation of different tests based on observations for external model evaluation of population analyses

(2009) Karl Brendel et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Clonidine as an Adjunct Therapy to Opioids for Neonatal Abstinence Syndrome: A Randomized, Controlled Trial

(2009) A. G. Agthe et al.   PEDIATRICS

Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial

(2008) K.J.S. Anand et al.   BRITISH JOURNAL OF ANAESTHESIA

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

(2008) Emmanuelle Comets et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE